Alivus Life Sciences Limited

Alivus Life Sciences Limited - Current Ratioverified

ALIVUS.NS

Price:

$1337.2

Market Cap:

$164.13B

Alivus Life Sciences Limited, a Mumbai, India-headquartered entity established in 2001, operates as a subsidiary of Nirma Limited. Having rebranded from Glenmark Life Sciences Limited in December 2024, the company specializes in the development, production, and global commercialization of active pharmaceutical ingredients (APIs). Its market footprint spans India, Japan, Europe, and both North and Latin America, supported by substantial export operations. Alivus Life Sciences provides an extensive catalog of APIs, including olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, r...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2021-08-06

Stock Exchange

NSE

Ticker

ALIVUS.NS

The Current Ratio as of October 2026 (TTM) for Alivus Life Sciences Limited (ALIVUS.NS) is 5.21

According to Alivus Life Sciences Limited’s latest financial reports and current stock price. The company's current Current Ratio is 5.21. This represents a change of 103.02% compared to the average of 2.57 of the last 4 quarters.

Alivus Life Sciences Limited (ALIVUS.NS) Historical Current Ratio (quarterly & annually)

How has ALIVUS.NS Current Ratio performed in the past?

The mean historical Current Ratio of Alivus Life Sciences Limited over the last ten years is 5.09. The current 5.21 Current Ratio has changed 10.14% with respect to the historical average. Over the past ten years (40 quarters), ALIVUS.NS's Current Ratio was at its highest in in the March 2026 quarter at 5.21. The Current Ratio was at its lowest in in the June 2024 quarter at 0.

Quarterly (TTM)
Annual

Average

5.09

Median

5.09

Minimum

4.97

Maximum

5.21

Alivus Life Sciences Limited (ALIVUS.NS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alivus Life Sciences Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 5.00%

Maximum Annual Current Ratio = 5.21

Minimum Annual Increase = 0%

Minimum Annual Current Ratio = 4.97

Quarterly (TTM)
Annual
YearCurrent RatioChange
20265.215.00%

Alivus Life Sciences Limited (ALIVUS.NS) Average Current Ratio

How has ALIVUS.NS Current Ratio performed in the past?

The current Current Ratio of Alivus Life Sciences Limited (ALIVUS.NS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.09

5-year avg

5.09

10-year avg

5.09

Alivus Life Sciences Limited (ALIVUS.NS) Current Ratio vs. Peers

How is ALIVUS.NS’s Current Ratio compared to its peers?

Alivus Life Sciences Limited’s Current Ratio is greater than Alembic Pharmaceuticals Limited (0), greater than Ipca Laboratories Limited (2.76), greater than NATCO Pharma Limited (0), less than Cohance Lifesciences Limited (5.38), greater than Bal Pharma Limited (0), greater than Morepen Laboratories Limited (0), greater than Laurus Labs Limited (0), greater than Granules India Limited (0), greater than SMS Pharmaceuticals Limited (0), greater than Aarti Pharmalabs Limited (0),

Build a custom stock screener for Alivus Life Sciences Limited (ALIVUS.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alivus Life Sciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alivus Life Sciences Limited (ALIVUS.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alivus Life Sciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Alivus Life Sciences Limited's Current Ratio?

How is the Current Ratio calculated for Alivus Life Sciences Limited (ALIVUS.NS)?

What is the highest Current Ratio for Alivus Life Sciences Limited (ALIVUS.NS)?

What is the 3-year average Current Ratio for Alivus Life Sciences Limited (ALIVUS.NS)?

What is the 5-year average Current Ratio for Alivus Life Sciences Limited (ALIVUS.NS)?

How does the current Current Ratio for Alivus Life Sciences Limited (ALIVUS.NS) compare to its historical average?